Literature DB >> 8766000

Bromoacetylcholine and acetylcholinesterase introduced via liposomes into motor nerve endings block increases in quantal size.

E Brailoiu1, W V der Kloot.   

Abstract

We incorporated bromoacetylcholine (an inhibitor of choline acetyltransferase), acetylcholinesterase, or both into liposomes made of phosphatidylcholine. Frog sartorius muscles were exposed to these liposomes for 30-60 min. The liposome treatment itself did not decrease the size of the quanta compared to untreated controls. Then the preparations were exposed for 10-20 min to a hypertonic solution, which increases the rate of spontaneous quantal release and elicits an increase in the amount of acetylcholine released per quantum. Following the hypertonic treatment the quanta were significantly smaller in the liposome-treated preparations. Most of the difference occurred because in the preparations not exposed to the liposomes quantal size increased following the hypertonic treatment. This increase is thought to be due to the incorporation of more acetylcholine into each quantum. Our conclusions are that the treatments decreased the acetylcholine concentration in the cytoplasm, and that the increase in size occurs because additional acetylcholine is added to the vesicles containing the quanta from the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766000     DOI: 10.1007/s004240050152

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  28 in total

1.  Spontaneous subthreshold activity at motor nerve endings.

Authors:  P FATT; B KATZ
Journal:  J Physiol       Date:  1952-05       Impact factor: 5.182

2.  Role of disulphide bonds in burst-like activity of nicotinic acetylcholine receptor channels in rat sympathetic neurones.

Authors:  V A Derkach; D E Kurenny; A I Melishchuk; A A Selyanko; V I Skok
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

3.  Choline acetyltransferase: reversible inhibition by bromoacetyl coenzyme A and bromoacetylcholine.

Authors:  R Roskoski
Journal:  Biochemistry       Date:  1974-05-21       Impact factor: 3.162

4.  Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction.

Authors:  W Van der Kloot
Journal:  J Neurophysiol       Date:  1987-05       Impact factor: 2.714

5.  Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes.

Authors:  A de Paiva; J O Dolly
Journal:  FEBS Lett       Date:  1990-12-17       Impact factor: 4.124

6.  Increasing quantal size at the mouse neuromuscular junction and the role of choline.

Authors:  S P Yu; W Van der Kloot
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

7.  The synthesis of acetylcholine in skeletal muscles of the rat.

Authors:  S Tucek
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

8.  Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction.

Authors:  W Van der Kloot; D D Brănişteanu
Journal:  Pflugers Arch       Date:  1992-03       Impact factor: 3.657

9.  Studies of reversible and irreversible interactions of an alkylating agonist with Torpedo californica acetylcholine receptor in membrane-bound and purified states.

Authors:  H P Moore; M A Raftery
Journal:  Biochemistry       Date:  1979-05-15       Impact factor: 3.162

10.  Neurotransmitter release evoked by nerve impulses without Ca2+ entry through Ca2+ channels in frog motor nerve endings.

Authors:  E M Silinsky; M Watanabe; R S Redman; R Qiu; J K Hirsh; J M Hunt; C S Solsona; S Alford; R C MacDonald
Journal:  J Physiol       Date:  1995-02-01       Impact factor: 5.182

View more
  3 in total

1.  Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta.

Authors:  E Brailoiu; C M Filipeanu; A Tica; C P Toma; D de Zeeuw; S A Nelemans
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Calmodulin increases transmitter release by mobilizing quanta at the frog motor nerve terminal.

Authors:  Eugen Brailoiu; Michael D Miyamoto; Nae J Dun
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.

Authors:  William Van der Kloot; Jordi Molgó; Roger Cameron; Cesare Colasante
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.